Corrigendum to " Immunological priming induced by a two-dose series of H5N1 influenza antigen, administered alone or in combination with two different formulations of AS03 adjuvant in adults: Results of a randomised single heterologous booster dose study at 15 months" [Vaccine 29 (2011) 6408-6418]

Vaccine

Volumn 31, Issue 2, 2013, Pages 436-437

  Risi, George ^a   Frenette, Louise ^b   Langley, Joanne M ^c   Li, Ping ^d   Riff, Dennis ^e   Sheldon, Eric ^f   Vaughn, David W ^d   Fries, Louis ^d  

^a Infectious Disease Specialists   (United States)

^b QT Research   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d GLAXOSMITHKLINE   (United States)

^e Clinical Research Institute   (United States)

^f MIAMI RESEARCH ASSOCIATES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERRATUM; ERROR; PRIORITY JOURNAL; ADULT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; IMMUNIZATION; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A H5N1; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL; VACCINATION;

IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; VIRUS ANTIGEN;

ADJUVANTS, IMMUNOLOGIC; ADULT; ANTIGENS, VIRAL; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; VACCINATION;

EID: 84871392747     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.11.002     Document Type: Erratum

References (0)